Vir Biotechnology: The Low-Down On The Readouts Ahead
Source: SeekingAlpha
2026-02-05 21:24:29 ET
...
Read the full article on Seeking Alpha
For further details see:
Vir Biotechnology: The Low-Down On The Readouts Ahead
Janux Therapeutics Inc.
NASDAQ: JANX
JANX Trading
-0.87% G/L:
$13.65 Last:
293,292 Volume:
$13.67 Open:
JANX Latest News
February 26, 2026 04:01:00 pm
Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 17, 2026 07:00:00 am
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
January 26, 2026 07:00:00 am
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
JANX Stock Data
$789,139,228
45,531,890
1.75%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
